[Retracted] Cisapride versus Maren Pill for Functional Constipation: A Meta-Analysis

Table 1

Basic characteristics of the included studies.

First author	Publication year	Group (n)	Patients age, years	Sex (M : F)	Duration, months	Effective	Ineffective	Adverse events	Recurrence	NOS
He et al.	2010	Cisapride (50)	21～63	24 : 26	>12	43	7	3	10	7
		Maren (50)	22～65	29 : 21	>12	23	27	0	13
Liu et al.	2017	Cisapride (48)	64.5 ± 6.5	29 : 19	NA	45	3	NA	NA	8
		Maren (48)	64.1 ± 7.3	27 : 21	NA	34	14	NA	NA
Shi et al.	2003	Cisapride (40)	18～74	25 : 15	NA	36	4	NA	NA	7
		Maren (20)	19～70	10 : 10	NA	15	5	NA	NA
Yang et al.	2017	Cisapride (49)	50.21 ± 1.17	29 : 20	NA	45	4	3	5	8
		Maren (49)	51.45 ± 1.25	28 : 21	NA	35	14	10	15
Zhang et al.	2019	Cisapride (30)	38.75 ± 5.73	17 : 13	6.35 ± 2.61	28	2	2	6	8
		Maren (30)	38.69 ± 5.68	18 : 12	6.42 ± 2.58	21	9	8	14

Notes: M, male; F, female; NA, not available; age: mean ± standard deviation (SD) or range; NOS: Newcastle–Ottawa Scale.